This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Azurity Pharmaceuticals Ireland Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Krishna Mohan Lakshmipathula
Introduction
Krishna Mohan Lakshmipathula is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical therapy. His work focuses on improving treatments for conditions such as epilepsy and bipolar disorder.
Latest Patents
Krishna Mohan Lakshmipathula holds a patent for "Lamotrigine salts, co-crystals, and compositions." This patent relates to innovative lamotrigine salts, co-crystals, and compositions that can be utilized in medical therapies. The lamotrigine salt may be a lamotrigine dicarboxylic acid salt or a hydrate or solvate thereof. The co-crystal can be a combination of lamotrigine and a dicarboxylic acid, or a hydrate or solvate thereof. The compositions can be in various forms, including powder or liquid, and are designed for therapeutic use in treating epilepsy or bipolar disorder. He has 1 patent to his name.
Career Highlights
Krishna Mohan Lakshmipathula is currently associated with Azurity Pharmaceuticals Ireland Limited, where he continues to innovate in the pharmaceutical sector. His expertise and dedication to research have positioned him as a valuable asset in his field.
Collaborations
He has collaborated with notable colleagues, including Jordan R Hunt and Gerold Mosher, to advance his research and development efforts.
Conclusion
Krishna Mohan Lakshmipathula's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments. His work in developing lamotrigine salts and compositions is a testament to his expertise and dedication to enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile